SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 737.59 |
| Enterprise Value ($M) | 949.14 |
| Book Value ($M) | 776.41 |
| Book Value / Share | 5.47 |
| Price / Book | 0.95 |
| NCAV ($M) | 14.01 |
| NCAV / Share | 0.10 |
| Price / NCAV | 52.65 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.16 |
| Return on Assets (ROA) | -0.10 |
| Return on Equity (ROE) | -0.25 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.94 |
| Current Ratio | 10.74 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 679.10 |
| Assets | 1,278.21 |
| Liabilities | 665.09 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Point72 Asset Management, L.P. | 2.60 | -44.53 | |
| 13G/A | 12 West Capital Management LP | 9.90 | 20.75 | |
| 13G/A | Maravai Life Sciences Holdings 2, Llc | 51.81 | -7.06 | |
| 13G | BlackRock, Inc. | 7.40 | 0.00 | |
| 13G/A | Millennium Management Llc | 3.10 | -39.31 | |
| 13G/A | Vanguard Group Inc | 7.57 | -3.72 | |
| 13G/A | Massachusetts Financial Services Co /ma/ | 4.60 | -53.57 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 738,969 | 3,800,008 | 19.45 | |
| 438,226 | 2,031,769 | 21.57 | |
| 418,959 | 1,931,931 | 21.69 | |
| 295,655 | 2,280,960 | 12.96 | |
| 691,763 | 5,088,177 | 13.60 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MNMD – Mind Medicine (MindMed) Inc. | MRNA – Moderna, Inc. |
| MRSN – Mersana Therapeutics, Inc. | MYGN – Myriad Genetics, Inc. |
| NBIX – Neurocrine Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io